Aminoglycosides: Is there an effective alternative in severe tularaemia? A case series
Infection · 2026-10 · 54 (5) · 2981-2985
DOI: 10.1007/s15010-026-02854-3 ↗Kurz gefasst
Fallbericht in der Zeitschrift Infection, online erschienen am 15.07.2026. Verfasst von Markus Fiedler und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine 4 - Pneumology, Kepler University Hospital, Linz, Austria. Hauptthemen laut MEDLINE: Tularemia, Anti-Bacterial Agents, Francisella tularensis, Fluoroquinolones. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johannes Kepler University Linz.
Abstract (Originalsprache)
Purpose Severe pulmonary tularaemia is rare, and evidence guiding optimal antimicrobial treatment remains limited. Although aminoglycosides are commonly recommended, their toxicity profile and practical limitations may complicate treatments. The purpose of this case series was to describe clinical outcomes in adult patients with severe pulmonary tularaemia caused by Francisella tularensis who were treated with fluoroquinolones or tetracyclines.; Methods We retrospectively describe six adult patients with severe pulmonary tularaemia. Clinical presentation, antimicrobial treatment, and clinical and radiological outcomes were reviewed, with a focus on response to targeted therapy with fluoroquinolones or tetracyclines.; Results All six patients achieved complete clinical and radiological recovery following targeted antimicrobial therapy with either fluoroquinolones or tetracyclines despite severe pulmonary disease.; Conclusion This case series provides consistent real-world evidence that fluoroquinolones and tetracyclines can achieve favourable outcomes in severe pulmonary tularaemia. These findings highlight their potential role as alternative treatment strategies and contribute meaningful data to the ongoing discussion on optimal antimicrobial management of tularaemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine 4 - Pneumology, Kepler University Hospital, Linz, Austria.
- Medical Faculty, Johannes Kepler University, Linz, Austria.
- Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine 4 - Pneumology, Kepler University Hospital, Krankenhausstrasse 9, 4021, Linz, Austria.
- Ignaz Semmelweis Institut, Interuniversity Institute for Infection Research, Vienna, Austria.
- Medical Faculty, Johannes Kepler University, Linz, Austria. Thierry.rolling@jku.at.
- Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine 4 - Pneumology, Kepler University Hospital, Krankenhausstrasse 9, 4021, Linz, Austria. Thierry.rolling@jku.at.
Förderung
- Johannes Kepler University Linz
Zitieren
APA
Fiedler, M., Neuböck, M. J., Eimer, J., Ablinger, G., Murauer, G., Salzer, H. J. F., & Rolling, T. (2026). Aminoglycosides: Is there an effective alternative in severe tularaemia? A case series. Infection, 54(5), 2981-2985. https://doi.org/10.1007/s15010-026-02854-3
Vancouver
Fiedler M, Neuböck MJ, Eimer J, Ablinger G, Murauer G, Salzer HJF, et al. Aminoglycosides: Is there an effective alternative in severe tularaemia? A case series. Infection. 2026;54(5):2981-2985. doi:10.1007/s15010-026-02854-3
BibTeX
@article{Fiedler2026,
author = {Fiedler, Markus and Neuböck, Matthias J and Eimer, Johannes and Ablinger, Gregor and Murauer, Georg and Salzer, Helmut J F and Rolling, Thierry},
title = {Aminoglycosides: Is there an effective alternative in severe tularaemia? A case series},
journal = {Infection},
year = {2026},
volume = {54},
number = {5},
pages = {2981--2985},
doi = {10.1007/s15010-026-02854-3}
}
EUVIMED